These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 25133794)

  • 1. Effects of fenofibric acid on diabetic macular edema: the MacuFen study.
    Massin P; Peto T; Ansquer JC; Aubonnet P; MacuFEN Study Investigators FT
    Ophthalmic Epidemiol; 2014 Oct; 21(5):307-17. PubMed ID: 25133794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term effect of intravitreal bevacizumab (avastin) in patients with chronic diffuse diabetic macular edema.
    Kook D; Wolf A; Kreutzer T; Neubauer A; Strauss R; Ulbig M; Kampik A; Haritoglou C
    Retina; 2008 Oct; 28(8):1053-60. PubMed ID: 18779710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravitreal triamcinolone acetonide for diabetic diffuse macular edema: preliminary results of a prospective controlled trial.
    Massin P; Audren F; Haouchine B; Erginay A; Bergmann JF; Benosman R; Caulin C; Gaudric A
    Ophthalmology; 2004 Feb; 111(2):218-24; discussion 224-5. PubMed ID: 15019365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An extension of the Early Treatment Diabetic Retinopathy Study (ETDRS) system for grading of diabetic macular edema in the Astemizole Retinopathy Trial.
    Gardner TW; Sander B; Larsen ML; Kunselman A; Tenhave T; Lund-Andersen H; Reimers J; Hubbard L; Blankenship GW; Quillen DA; Brod RD; Wilmarth MH; Post-Hansen H; Parving HH; Davis MD
    Curr Eye Res; 2006 Jun; 31(6):535-47. PubMed ID: 16769613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical dexamethasone-cyclodextrin microparticle eye drops for diabetic macular edema.
    Tanito M; Hara K; Takai Y; Matsuoka Y; Nishimura N; Jansook P; Loftsson T; Stefánsson E; Ohira A
    Invest Ophthalmol Vis Sci; 2011 Oct; 52(11):7944-8. PubMed ID: 21896859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravitreal triamcinolone for refractory diabetic macular edema: two-year results of a double-masked, placebo-controlled, randomized clinical trial.
    Gillies MC; Sutter FK; Simpson JM; Larsson J; Ali H; Zhu M
    Ophthalmology; 2006 Sep; 113(9):1533-8. PubMed ID: 16828501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early change of central macular thickness after intravitreous triamcinolone or bevacizumab in diabetic macular edema or retinal vein occlusion.
    Sonoda Y; Arimura N; Shimura M; Sakamoto T
    Retina; 2011 Feb; 31(2):290-7. PubMed ID: 21102366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema.
    Haritoglou C; Kook D; Neubauer A; Wolf A; Priglinger S; Strauss R; Gandorfer A; Ulbig M; Kampik A
    Retina; 2006; 26(9):999-1005. PubMed ID: 17151486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravitreal triamcinolone acetonide for diffuse diabetic macular edema: phase 2 trial comparing 4 mg vs 2 mg.
    Audren F; Lecleire-Collet A; Erginay A; Haouchine B; Benosman R; Bergmann JF; Gaudric A; Massin P
    Am J Ophthalmol; 2006 Nov; 142(5):794-99. PubMed ID: 16978576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravitreal triamcinolone as an adjunct to standard laser therapy in coexisting high-risk proliferative diabetic retinopathy and clinically significant macular edema.
    Mirshahi A; Shenazandi H; Lashay A; Faghihi H; Alimahmoudi A; Dianat S
    Retina; 2010 Feb; 30(2):254-9. PubMed ID: 20057344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the magnitude and time course of macular thinning induced by different interventions for diabetic macular edema: implications for sequence of application.
    Browning DJ; Fraser CM; Powers ME
    Ophthalmology; 2006 Oct; 113(10):1713-9. PubMed ID: 16889833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficiency of fenofibrate in facilitating the reduction of central macular thickness in diabetic macular edema.
    Srinivasan S; Hande P; Shetty J; Murali S
    Indian J Ophthalmol; 2018 Jan; 66(1):98-105. PubMed ID: 29283132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional and morphological changes in diabetic macular edema over the course of anti-vascular endothelial growth factor treatment.
    Reznicek L; Cserhati S; Seidensticker F; Liegl R; Kampik A; Ulbig M; Neubauer AS; Kernt M
    Acta Ophthalmol; 2013 Nov; 91(7):e529-36. PubMed ID: 23647578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The DA VINCI Study: phase 2 primary results of VEGF Trap-Eye in patients with diabetic macular edema.
    Do DV; Schmidt-Erfurth U; Gonzalez VH; Gordon CM; Tolentino M; Berliner AJ; Vitti R; Rückert R; Sandbrink R; Stein D; Yang K; Beckmann K; Heier JS
    Ophthalmology; 2011 Sep; 118(9):1819-26. PubMed ID: 21546089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporal variation in diabetic macular edema measured by optical coherence tomography.
    Frank RN; Schulz L; Abe K; Iezzi R
    Ophthalmology; 2004 Feb; 111(2):211-7. PubMed ID: 15019364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optical coherence tomographic pattern may predict visual outcome after intravitreal triamcinolone for diabetic macular edema.
    Gibran SK; Khan K; Jungkim S; Cleary PE
    Ophthalmology; 2007 May; 114(5):890-4. PubMed ID: 17467527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship of macular thickness to clinically graded diabetic retinopathy severity in eyes without clinically detected diabetic macular edema.
    Browning DJ; Fraser CM; Clark S
    Ophthalmology; 2008 Mar; 115(3):533-539.e2. PubMed ID: 18067962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Darapladib, a lipoprotein-associated phospholipase A2 inhibitor, in diabetic macular edema: a 3-month placebo-controlled study.
    Staurenghi G; Ye L; Magee MH; Danis RP; Wurzelmann J; Adamson P; McLaughlin MM;
    Ophthalmology; 2015 May; 122(5):990-6. PubMed ID: 25749297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of intravitreal versus posterior sub-Tenon's capsule injection of triamcinolone acetonide for diffuse diabetic macular edema.
    Cardillo JA; Melo LA; Costa RA; Skaf M; Belfort R; Souza-Filho AA; Farah ME; Kuppermann BD
    Ophthalmology; 2005 Sep; 112(9):1557-63. PubMed ID: 16019075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Triamcinolone in the treatment of the diabetic macular edema--one-year results].
    Dusová J; Studnicka J; Rencová E; Korda V; Hejcmanová D
    Cesk Slov Oftalmol; 2008 Jul; 64(4):149-52. PubMed ID: 18780654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.